Log in to save to my catalogue

Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measu...

Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4853214

Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy

About this item

Full title

Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy

Publisher

Canada: Joule Inc

Journal title

Journal of psychiatry & neuroscience, 2016-05, Vol.41 (3), p.E37-E45

Language

English

Formats

Publication information

Publisher

Canada: Joule Inc

More information

Scope and Contents

Contents

Background GABAergic and glutamatergic neurotransmitter systems are central to the pathophysiology of depression and are potential targets of repetitive transcranial magnetic stimulation (rTMS). We assessed the effect of 10-Hz rTMS over the left dorsolateral prefrontal cortex (DLPFC) of patients with major depressive disorder on the levels of media...

Alternative Titles

Full title

Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4853214

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4853214

Other Identifiers

ISSN

1180-4882

E-ISSN

1488-2434

DOI

10.1503/jpn.150223

How to access this item